Bayer Group Consolidated Statements of Recognized Income and Expense

	1st Quarter 2007	1st Quarter 2008
€ million
Changes in fair values of derivatives designated as hedges and available-for-sale financial assets, recognized in stockholders’ equity	1	42
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits and effects of the limitation on pension plan assets, recognized in stockholders’ equity	331	817
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	36	(552)
Deferred taxes on valuation adjustments offset directly against stockholders’ equit	(134)	(261)
Changes due to changes in scope of consolidation	31	1
Revaluation surplus (IFRS 3)	-	4
Minority interest in partnerships, recognized in liabilities	-	(20)
Valuation adjustments recognized directly in stockholders’ equity	265	31
Income after taxes	2,810	762
Total income and expense recognized in the financial statements	3,075	793
of which attributable to minority interest	2	(1)
of which attributable to Bayer AG stockholders	3,073	794